Brenden C Park

University of Texas Southwestern Medical Center, Dallas, TX, United States 
"Brenden Park"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Shekhar S, Moehlman AT, Park B, et al. (2023) Allnighter pseudokinase-mediated feedback links proteostasis and sleep in Drosophila. Nature Communications. 14: 2932
Meng D, Yang Q, Melick CH, et al. (2021) ArfGAP1 inhibits mTORC1 lysosomal localization and activation. The Embo Journal. e106412
Kim SH, Cho JH, Park BO, et al. (2021) Phosphorylation of REPS1 at Ser709 by RSK attenuates the recycling of Transferrin receptor. Bmb Reports
Cho JH, Kim K, Kim SA, et al. (2020) Deubiquitinase OTUD5 is a positive regulator of mTORC1 and mTORC2 signaling pathways. Cell Death and Differentiation
Kim K, Park SG, Park BC, et al. (2020) Serine 389 phosphorylation of 3-phosphoinositide-dependent kinase 1 by UNC-51-like kinase 1 affects its ability to regulate Akt and p70 S6kinase. Bmb Reports
Sreelatha A, Nolan C, Park BC, et al. (2020) A effector kinase is activated by host inositol hexakisphosphate. The Journal of Biological Chemistry
Kim K, Lee DH, Park S, et al. (2019) Disordered region of cereblon is required for efficient degradation by proteolysis-targeting chimera. Scientific Reports. 9: 19654
Lopez VA, Park BC, Nowak D, et al. (2019) A Bacterial Effector Mimics a Host HSP90 Client to Undermine Immunity. Cell
Park BC, Reese M, Tagliabracci VS. (2019) Thinking outside of the cell: Secreted protein kinases in bacteria, parasites, and mammals. Iubmb Life
Kim SA, Go A, Jo SH, et al. (2019) A novel cereblon modulator for targeted protein degradation. European Journal of Medicinal Chemistry. 166: 65-74
See more...